Cargando…
The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism
STUDY OBJECTIVE: The primary aim of this study was to investigate whether IMA levels are helpful in the diagnosis of pulmonary embolism (PE). The secondary aim was to determine whether IMA was more effective alone or in combination with clinical probability scores in the diagnosis of PE. Thirdly, th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430960/ https://www.ncbi.nlm.nih.gov/pubmed/18513410 http://dx.doi.org/10.1186/1465-9921-9-49 |
_version_ | 1782156434065063936 |
---|---|
author | Turedi, Suleyman Gunduz, Abdulkadir Mentese, Ahmet Topbas, Murat Karahan, Suleyman C Yeniocak, Selman Turan, Ibrahim Eroglu, Oguz Ucar, Utku Karaca, Yunus Turkmen, Suha Russell, Robert M |
author_facet | Turedi, Suleyman Gunduz, Abdulkadir Mentese, Ahmet Topbas, Murat Karahan, Suleyman C Yeniocak, Selman Turan, Ibrahim Eroglu, Oguz Ucar, Utku Karaca, Yunus Turkmen, Suha Russell, Robert M |
author_sort | Turedi, Suleyman |
collection | PubMed |
description | STUDY OBJECTIVE: The primary aim of this study was to investigate whether IMA levels are helpful in the diagnosis of pulmonary embolism (PE). The secondary aim was to determine whether IMA was more effective alone or in combination with clinical probability scores in the diagnosis of PE. Thirdly, the sensitivity and specificity of IMA is compared with D-dimer both with and without clinical probability scores in patients with suspected PE. METHODS: Consecutive patients presenting to the emergency department with suspected PE were prospectively recruited, and healthy volunteers were also enrolled as controls. D-dimer and IMA levels were measured for the entire study group. Wells and Geneva scores were calculated and s-CTPA was performed on all suspected PE patients. RESULTS: The study population consisted of 130 patients with suspected PE and 59 healthy controls. Mean IMA levels were 0.362 ± 0.11 ABSU for Group A, the PE group (n = 75); 0.265 ± 0.07 ABSU for Group B, the non-PE group (n = 55); and 0.175 ± 0.05 ABSU for Group C, the healthy control group (p < 0.0001). At a cut-off point of 0.25 ABSU, IMA was 93% sensitive and 75% specific in the diagnosis of PE. PPV was 79.4% and NPV was 78.6%. Mean D-dimer levels were 12.48 ± 10.88 μg/ml for Group A; 5.36 ± 7.80 μg/ml for Group B and 0.36 ± 0.16 μg/ml for Group C (p < 0.0001). The D-dimer cut-off point was 0.81 μg/ml with a sensitivity of 98.9% and a specificity of 62.7%, PPV of 69.4% and NPV of 83.3%. The use of IMA in combination with Wells and Geneva clinical probability scores was determined to have a positive impact on these scores' sensitivity and negative predictive values. CONCLUSION: IMA is a good alternative to D-dimer in PE diagnosis in terms of both cost and efficiency. Used in combination with clinical probability scores, it has a similar positive effect on NPV and sensitivity to that of D-dimer. The PPV of IMA is better than D-dimer, but it is still unable to confirm a diagnosis of PE without additional investigation. |
format | Text |
id | pubmed-2430960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-24309602008-06-19 The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism Turedi, Suleyman Gunduz, Abdulkadir Mentese, Ahmet Topbas, Murat Karahan, Suleyman C Yeniocak, Selman Turan, Ibrahim Eroglu, Oguz Ucar, Utku Karaca, Yunus Turkmen, Suha Russell, Robert M Respir Res Research STUDY OBJECTIVE: The primary aim of this study was to investigate whether IMA levels are helpful in the diagnosis of pulmonary embolism (PE). The secondary aim was to determine whether IMA was more effective alone or in combination with clinical probability scores in the diagnosis of PE. Thirdly, the sensitivity and specificity of IMA is compared with D-dimer both with and without clinical probability scores in patients with suspected PE. METHODS: Consecutive patients presenting to the emergency department with suspected PE were prospectively recruited, and healthy volunteers were also enrolled as controls. D-dimer and IMA levels were measured for the entire study group. Wells and Geneva scores were calculated and s-CTPA was performed on all suspected PE patients. RESULTS: The study population consisted of 130 patients with suspected PE and 59 healthy controls. Mean IMA levels were 0.362 ± 0.11 ABSU for Group A, the PE group (n = 75); 0.265 ± 0.07 ABSU for Group B, the non-PE group (n = 55); and 0.175 ± 0.05 ABSU for Group C, the healthy control group (p < 0.0001). At a cut-off point of 0.25 ABSU, IMA was 93% sensitive and 75% specific in the diagnosis of PE. PPV was 79.4% and NPV was 78.6%. Mean D-dimer levels were 12.48 ± 10.88 μg/ml for Group A; 5.36 ± 7.80 μg/ml for Group B and 0.36 ± 0.16 μg/ml for Group C (p < 0.0001). The D-dimer cut-off point was 0.81 μg/ml with a sensitivity of 98.9% and a specificity of 62.7%, PPV of 69.4% and NPV of 83.3%. The use of IMA in combination with Wells and Geneva clinical probability scores was determined to have a positive impact on these scores' sensitivity and negative predictive values. CONCLUSION: IMA is a good alternative to D-dimer in PE diagnosis in terms of both cost and efficiency. Used in combination with clinical probability scores, it has a similar positive effect on NPV and sensitivity to that of D-dimer. The PPV of IMA is better than D-dimer, but it is still unable to confirm a diagnosis of PE without additional investigation. BioMed Central 2008 2008-05-30 /pmc/articles/PMC2430960/ /pubmed/18513410 http://dx.doi.org/10.1186/1465-9921-9-49 Text en Copyright © 2008 Turedi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Turedi, Suleyman Gunduz, Abdulkadir Mentese, Ahmet Topbas, Murat Karahan, Suleyman C Yeniocak, Selman Turan, Ibrahim Eroglu, Oguz Ucar, Utku Karaca, Yunus Turkmen, Suha Russell, Robert M The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism |
title | The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism |
title_full | The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism |
title_fullStr | The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism |
title_full_unstemmed | The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism |
title_short | The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism |
title_sort | value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430960/ https://www.ncbi.nlm.nih.gov/pubmed/18513410 http://dx.doi.org/10.1186/1465-9921-9-49 |
work_keys_str_mv | AT turedisuleyman thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT gunduzabdulkadir thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT menteseahmet thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT topbasmurat thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT karahansuleymanc thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT yeniocakselman thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT turanibrahim thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT erogluoguz thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT ucarutku thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT karacayunus thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT turkmensuha thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT russellrobertm thevalueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT turedisuleyman valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT gunduzabdulkadir valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT menteseahmet valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT topbasmurat valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT karahansuleymanc valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT yeniocakselman valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT turanibrahim valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT erogluoguz valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT ucarutku valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT karacayunus valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT turkmensuha valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism AT russellrobertm valueofischemiamodifiedalbumincomparedwithddimerinthediagnosisofpulmonaryembolism |